Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-072037
Filing Date
2025-05-15
Accepted
2025-05-15 08:45:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10175
  Complete submission text file 0000950170-25-072037.txt   12009
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Subject) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88910 | Film No.: 25949000
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address FORBION CAPITAL PARTNERS GOOIMEER 2-35 NAARDEN P7 1411
Business Address FORBION CAPITAL PARTNERS GOOIMEER 2-35 NAARDEN P7 1411 31 356993000
ForGrowth III PA B.V. (Filed by) CIK: 0002050902 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A